About the Authors
- Arne Christians
-
Affiliation Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Christian Hartmann
-
* E-mail: hartmann.christian@mh-hannover.de
Affiliation Department of Neuropathology, Institute of Pathology, Hannover Medical School (MHH), Hannover, Germany
- Axel Benner
-
Affiliation Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Jochen Meyer
-
Affiliation Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Andreas von Deimling
-
Affiliations Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany
- Michael Weller
-
Affiliations Department of Neurology, University Hospital Zurich, Zurich, Switzerland, Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
- Wolfgang Wick
-
Affiliations Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Neurooncology at the National Center for Tumour Diseases, Heidelberg University Hospital, Heidelberg, Germany, Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
- Markus Weiler
-
Affiliations Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Neurooncology at the National Center for Tumour Diseases, Heidelberg University Hospital, Heidelberg, Germany, Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
Competing Interests
M. Weller has been a consultant to, and has received honoraria from MSD (former Schering-Plough, one company which manufactures temozolomide) and Oncomethylome Sciences. W. Wick has been a consultant to, and has received honoraria from MSD, Roche and Eli Lilly. All other authors have declared no conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AC CH AvD M. Weiler. Performed the experiments: AC JM. Analyzed the data: AC CH AB M. Weiler. Contributed reagents/materials/analysis tools: AVD M. Weiler WW. Wrote the paper: AC CH AB AvD M. Weller WW M. Weiler.